Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study | Synapse
May 23, 2024Open Access
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
For the French translation of the abstract see Supplementary Materials section.